Skip to main content
SpringerLink
Log in

Vergleichende Studie des Einsatzes von Erythropoietin (i.v. vs. s.c.) zur Korrektur der renalen Anämie

  • Conference paper
Nephrologie

Part of the book series: Innovative Aspekte der klinischen Medizin ((KLIN MED,volume 2))

  • 27 Accesses

Zusammenfassung

Die Wirksamkeit von rhEPO hinsichtlich der Korrektur einer renalen Anämie ist durch klinische Studien belegt [1, 5, 6, 11, 13].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Bommer J, Alexiou C, Müller-Bühl E, Eifert J, Ritz E (1987) Recombinant human erythropoietin therapy in haemodialysis patients — dose determination and clinical experience. Nephrol Dial Transplant 2:238–242

    PubMed  CAS  Google Scholar 

  2. Bommer J, Ritz E, Weinreich T, Bommer G, Ziegler T (1988) Subcutaneous erythropoietin. Lancet II:406

    Article  Google Scholar 

  3. Bommer J, Samtleben W, Koch KM, Baldamus CA, Grützmacher P, Scigalla P (1989) Variations of recombinant human erythropoietin application in hemodialysis patients. Contrib Nephrol 76:149–156

    PubMed  CAS  Google Scholar 

  4. Casati S, Passerini P, Campise MR, Graziani G, Cesana B, Perisic N, Ponticelli C (1987) Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having hemodialysis. Dr Med J 295:1017–1021

    Article  CAS  Google Scholar 

  5. Eschbach JW, Egrie JC, Downing MR, Browne JK, Adamson JW (1987) Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. N Engl J Med 316:73–78

    Article  PubMed  CAS  Google Scholar 

  6. Eschbach JW, Downing MR, Egrie JC, Browne JK, Adamson JW (1989) USA Multicenter Clinical Trial with Recombinant Human Erythropoietin (Amgen). Contrib Nephrol 76:160–165

    PubMed  CAS  Google Scholar 

  7. Granolleras C, Branger B, Bean MC, Deschodt G, Alsabadani B, Shaldon S (1989) Experience with daily self-administered subcutaneous erythropoietin Contrib Nephrol 76:143–148

    CAS  Google Scholar 

  8. Grützmacher P, Bergmann M, Weinreich T, Nattermann U, Reimers E, Pollok N (1988) Beneficial and adverse effects of correction of anaemia by recombinant human erythropoietin in patients on maintenance haemodialysis. Contrib Nephrol 66:104–113

    PubMed  Google Scholar 

  9. Kampf D, Kahl A, Passlick J, Pustelnik A, Eckardt K-U, Ehmer B, Jacobs C, Baumelou A, Grabensee B, Gahl GM (1989) Single-dose kinetics of recombinant human erythropoietin after intravenous, subcutaneous and intraperitoneal administration. Preliminary results. Contrib Nephrol 76:106–111

    PubMed  CAS  Google Scholar 

  10. Kühn K, Nonnast-Daniel B, Grützmacher P, Grüner J, Pfäffl W, Baldamus CA, Scigalla P (1988) Analysis of initial resistance of erythropoiesis to treatment with recombinant human erythropoietin. Contrib Nephrol 66:94–103

    PubMed  Google Scholar 

  11. Pollok M, Bommer J, Gurland HJ, Koch KM, Schoeppe W, Scigalla P, Baldamus CA (1989) Effects of recombinant human erythropoietin treatment in end-stage renal failure patients. Results of a multicenter phase II/III study. Contrib Nephrol 76:201–211

    PubMed  CAS  Google Scholar 

  12. Samtleben W, Baldamus CA, Bommer J, Fassbinder W, Nonnast-Daniel B, Gurland HJ (1988) Blood pressure changes during treatment with recombinant human erythropoietin. Contrib Nephrol 66:114–122

    PubMed  CAS  Google Scholar 

  13. Winearis CG, Oliver D, Pippard MJ, Reid C, Downing MR, Cotes PM (1986) Effect of human erythropoietin derived recombinant DNA on the anemia of patients maintained by chronic hemodialysis. Lancet II:1175–1178

    Article  Google Scholar 

  14. Zehnter E, Pollok M, Ziegenhagen D, Bramsiepe P, Longere F, Baldamus CA, Wellner U, Waters W (1988) Urea kinetics in patients on regular dialysis treatment before and after treatment with recombinant human erythropoietin. Contrib Nephrol 66:149–155

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. G. Stein
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Sperschneider
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Thieler
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. W. Dutz
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S. Hans
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. D. Voigt
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Marx
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. J. Engelmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. P. Scigalla
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abteilung Nephrologie Zentrum für Innere Medizin und Dermatologie, Medizinische Hochschule Hannover, Konstanty-Gutschow-Straße 8, W-3000, Hannover, Deutschland

    K. M. Koch

  2. Sektion Pharmakotherapie, Universität Ulm, Steinhövelstraße 9, W-7900, Ulm, Deutschland

    J. Rosenthal

  3. Pathophysiologisches Institut, Universität Bern, Murtenstraße 35, CH-3010, Bern, Switzerland

    H. Fleisch

  4. Forschung Klinik Nephrologie/Onkologie, Boehringer Mannheim GmbH, Sandhofer Straße 116, W-6800, Mannheim 31, Deutschland

    P. Scigalla

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Stein, G. et al. (1992). Vergleichende Studie des Einsatzes von Erythropoietin (i.v. vs. s.c.) zur Korrektur der renalen Anämie. In: Koch, K.M., Rosenthal, J., Fleisch, H., Scigalla, P. (eds) Nephrologie. Innovative Aspekte der klinischen Medizin, vol 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76708-1_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76708-1_4

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-54173-8

  • Online ISBN: 978-3-642-76708-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation